251 286 - Biotech Bayern

26
Regensburg – Biotech on the Danube
BioPark Regensburg GmbH is the administrative centre and
management unit of the BioRegio Regensburg biotechnology
cluster in Eastern Bavaria. There are 40 companies
with more than 2400 employees currently working in the
field of life sciences in the BioRegio Regensburg cluster.
These include 26 companies with 900 employees working
in the core area of biotechnology. After Munich, this makes
Regensburg the second largest biotechnology region in
Bavaria.
Research at the university
location Regensburg
Regensburg University, the University of Applied Sciences
and the Medical Centre currently employ a total of 7,000
people; altogether there are 24,000 students. Along with
metabolic physiology and immunology (SFB – Collaborative
Research Centres, DFG – German Research Foundation),
research is concentrated especially on the neurosciences
(BMBF – Federal Ministry of Education and Research). It has
been possible to engage the José Carreras Foundation to
support haematological therapy research using adult stem
cells. The “Human Tissue & Cell Research” Foundation was
founded on site with the aim of developing new therapeutic
methods for patients with liver diseases. The development
of vaccines to combat the HIV virus (AIDS) receives substantial
funding from the Bill & Melinda Gates Foundation.
In the field of infection biology, the Medical Centre is a
partner of the World Health Organisation (WHO). Since 2007,
the Fraunhofer Project Group for the Diagnosis and Treatment
of Tumors, Metabolic Diseases and Diseases associated
with Aging has been located in the BioPark as an extra-mural
research unit.
The BioPark at the business
location Regensburg
The development of innovative technologies in and around
the city is booming: During the last few years the region has
become one of Bavaria's fastest growing economic regions.
Through the foundation of BioPark Regensburg GmbH in
1998, the City created yet another catalyst for this aspiring
future-oriented sector. With support from the State of
Bavaria, the BioPark was built directly on the university
campus at a cost of � 36 million in two phases, in 2001 and
2006. The multifunctional buildings offer 12,000 square
metres of state of the art laboratory, office and storage
space for companies and institutes working in the fields of
biotechnology, medical technology and associated services.
At present, the BioPark accommodates 22 leaseholders and
a 500-strong workforce.
Successes “Made in Regensburg”
In 2006, BioRegio Regensburg celebrated its 10th anniversary.
During this time more than � 100 million
were invested in the development of Life Sciences.
The return of investment is impressive; 27 companies
have been founded since 1996 alone
and the number of employees in the
region has increased more than fivefold
to 2400. BioPark companies regularly
receive awards for their innovative
business ideas. Antisense Pharma